Ellumigen

Ellumigen, formerly known as Ocean Genomics, is a San Francisco-based AI/ML company that has developed an end-to-end, cloud-native platform for multi-omics data analysis. Its core product, Ellumigen Explorer™, accelerates translational research by processing raw sequencing data (RNA-seq, DNA-seq, etc.) into a structured database and enabling interactive exploration via a natural language chat interface. The company targets biopharma innovators, translational researchers, and clinical trial teams, aiming to drastically reduce the time from raw data to biological insights. With the rebranding from Ocean Genomics, Ellumigen is positioning itself for a new phase of growth and platform advancement.

Ellumigen Explorer™: An end-to-end AI-powered translational multi-omics platform with a chat-based natural language interface. It processes raw sequencing data (RNA-seq, DNA-seq, miRNA-seq, Nanostring DSP) into a structured, high-performance database for zero-code exploration and analysis.

Ellumigen competes in a crowded market with well-funded bioinformatics platform companies like DNAnexus, Seven Bridges, and Partek, as well as the genomic analysis suites offered by major cloud providers (AWS, Google, Azure). Its key differentiator is the emphasis on a natural language, zero-code chat interface aimed at bench scientists, rather than just bioinformaticians.